Socioeconomic factors can have a significant impact on a patient’s health status and could be responsible for as much as 70%-80% of a patient’s overall health. These factors, called the social determinants of health (SDoH), define a patient’s day-to-day experiences. While the influence of such factors is well recognized, who ultimately is responsible for addressing SDoH in health care remains unclear. Physicians and other clinicians are suitably placed to assess SDoH factors that can impact clinical decision making. Understanding Medicare Advantage (MA)-contracted primary care provider (PCP) SDoH perceptions has yet to be fully explored.
The first biosimilar product filgrastim-sndz was approved by the FDA in 2015, but real-world evaluations of its uptake and cost in nationally representative populations are limited.
Legislative and Regulatory Position: The Academy of Managed Care Pharmacy (AMCP) supports regulatory and legislative provisions relating to opioid management that ensure appropriate patient access and treatment of uncontrolled pain, while limiting abuse and diversion of opioids and opioid potentiators. .